Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
Phase 2
Completed
- Conditions
- Non STEMIUnstable Angina
- Interventions
- Drug: Placebo comparator
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- Ischemix, LLC
- Target Recruit Count
- 361
- Registration Number
- NCT02103959
Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
Phase 2
Completed
- Conditions
- Stable Coronary Artery DiseasePercutaneous Coronary Intervention
- Interventions
- Drug: Placebo control
- First Posted Date
- 2009-09-25
- Last Posted Date
- 2011-06-20
- Lead Sponsor
- Ischemix, LLC
- Target Recruit Count
- 142
- Registration Number
- NCT00984802
- Locations
- 🇮🇳
Madras Medical Mission, Chennai, India
🇮🇳Hinduja Hospital, Mumbai, India
🇮🇳Poona Hospital, Pune, India
© Copyright 2025. All Rights Reserved by MedPath